DeltEx
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DeltEx, covering 2025-05-01 to 2025-05-01. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma [Phase 1, Phase 2]